Nishida N - Search Results

1

Embryonic MicroRNA-369 Controls Metabolic Splicing Factors and Urges Cellular Reprograming.

Konno M, Koseki J, Kawamoto K, Nishida N, Matsui H, Dewi DL, Ozaki M, Noguchi Y, Mimori K, Gotoh N, Tanuma N, Shima H, Doki Y, Mori M, Ishii H. Konno M, et al. Among authors: nishida n. PLoS One. 2015 Jul 15;10(7):e0132789. doi: 10.1371/journal.pone.0132789. eCollection 2015. PLoS One. 2015. PMID: 26176628 Free PMC article.

2

Abnormal expression of PFDN4 in colorectal cancer: a novel marker for prognosis.

Miyoshi N, Ishii H, Mimori K, Nishida N, Tokuoka M, Akita H, Sekimoto M, Doki Y, Mori M. Miyoshi N, et al. Among authors: nishida n. Ann Surg Oncol. 2010 Nov;17(11):3030-6. doi: 10.1245/s10434-010-1138-5. Epub 2010 Jun 15. Ann Surg Oncol. 2010. PMID: 20552408

3

FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma.

Nishida N, Mimori K, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M. Nishida N, et al. Ann Surg Oncol. 2011 Feb;18(2):535-42. doi: 10.1245/s10434-010-1274-y. Epub 2010 Aug 28. Ann Surg Oncol. 2011. PMID: 20803080

4

Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.

Takahashi H, Ishii H, Nishida N, Takemasa I, Mizushima T, Ikeda M, Yokobori T, Mimori K, Yamamoto H, Sekimoto M, Doki Y, Mori M. Takahashi H, et al. Among authors: nishida n. Ann Surg Oncol. 2011 Apr;18(4):1166-74. doi: 10.1245/s10434-010-1373-9. Epub 2010 Dec 2. Ann Surg Oncol. 2011. PMID: 21125339

5

Kinesin 18A expression: clinical relevance to colorectal cancer progression.

Nagahara M, Nishida N, Iwatsuki M, Ishimaru S, Mimori K, Tanaka F, Nakagawa T, Sato T, Sugihara K, Hoon DS, Mori M. Nagahara M, et al. Among authors: nishida n. Int J Cancer. 2011 Dec 1;129(11):2543-52. doi: 10.1002/ijc.25916. Epub 2011 Jun 9. Int J Cancer. 2011. PMID: 21213216 Free article.

6

MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.

Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M. Nishida N, et al. Clin Cancer Res. 2011 May 1;17(9):2725-33. doi: 10.1158/1078-0432.CCR-10-2132. Epub 2011 Jan 10. Clin Cancer Res. 2011. PMID: 21220473

7

MicroRNA miR-125b is a prognostic marker in human colorectal cancer.

Nishida N, Yokobori T, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Kuwano H, Mori M. Nishida N, et al. Int J Oncol. 2011 May;38(5):1437-43. doi: 10.3892/ijo.2011.969. Epub 2011 Mar 10. Int J Oncol. 2011. PMID: 21399871

8

Histone deacetylase 1 expression in gastric cancer.

Sudo T, Mimori K, Nishida N, Kogo R, Iwaya T, Tanaka F, Shibata K, Fujita H, Shirouzu K, Mori M. Sudo T, et al. Among authors: nishida n. Oncol Rep. 2011 Oct;26(4):777-82. doi: 10.3892/or.2011.1361. Epub 2011 Jun 27. Oncol Rep. 2011. PMID: 21725604

9

Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.

Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y, Mori M. Hashiguchi Y, et al. Among authors: nishida n. Int J Oncol. 2012 May;40(5):1477-82. doi: 10.3892/ijo.2012.1363. Epub 2012 Feb 9. Int J Oncol. 2012. PMID: 22322911

10

MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.

Nishida N, Yamashita S, Mimori K, Sudo T, Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y, Mori M. Nishida N, et al. Ann Surg Oncol. 2012 Sep;19(9):3065-71. doi: 10.1245/s10434-012-2246-1. Epub 2012 Feb 10. Ann Surg Oncol. 2012. PMID: 22322955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,300 results

Search Page